Allergy/Imm Medical News about vaccine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine
Vaccine , 09/14/09

Russell FM et al. – The aim was to identify an appropriate infant pneumococcal vaccination strategy for resource poor countries. By 12 months, differences between two and three doses persisted for serotype 14 only. Although GMC following three doses are higher than after two doses, the differences were small. A single dose may offer some protection for most serotypes.

<< Previous
Evaluation of a New Tumor Necrosis Factor-alpha-Inducing Membrane...

Next >>
Lymphoid tissue inducer cells: bridges between the ancient innate...

CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09 Relevance Score: 99%

A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09 Relevance Score: 97%

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09 Relevance Score: 97%

Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09 Relevance Score: 96%

H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09 Relevance Score: 95%